Gamma Investing LLC Genmab A/S Transaction History
Gamma Investing LLC
- $1.81 Trillion
- Q3 2025
A detailed history of Gamma Investing LLC transactions in Genmab A/S stock. As of the latest transaction made, Gamma Investing LLC holds 2,982 shares of GMAB stock, worth $97,332. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,982
Previous 1,919
55.39%
Holding current value
$97,332
Previous $39.6 Million
130.68%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GMAB
# of Institutions
242Shares Held
65.1MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$348 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$259 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$166 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$116 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$113 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $21.5B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...